Prot #ATI001-204: A Phase II Study of Ad-RTS-hIL-12 + Veledimex in Combination with Cemiplimab-rwlc (Libtayo®) in Subjects with Recurrent or Progressive Glioblastoma

Project: Research project

Project Details

StatusActive
Effective start/end date6/5/196/5/22

Funding

  • ZIOPHARM Oncology, Inc. (Prot #ATI001-204)